
Manchester South
Concerns raised5
Failure of GPs to recognise the link between the therapy and Pulmonary Fibrosis
Failure to seek early guidance from the prescribing secondary care physician
Failure to refer prescription amendments to the secondary care doctor for medication not started in primary care
CCG classification of the drug as green despite known side effects
Lack of GP awareness of escalation procedures for medication side effects
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.